Professor John Hooper and his team based at TRI, receives accolade that will allow them to progress ovarian cancer research to clinical trial.

Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients, as part of an Australian-first trial.

Dying to Know Day, held on 8 August, aims to encourage all Australians to talk about death by promoting conversations and community actions around death, dying and bereavement.

A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.

A recent Mater Research protocol submitted to the NHMRC has demonstrated the vital role consumers play in shaping and improving research trials.